Genome-wide scan of everyone possible for Etiologic, Prevention, and Clinical Outcome Research |
Wen-Yi Jung |
NCI |
PLCO |
Jan 23, 2018 |
2017-9000 |
Male pattern baldness: is there an association with bladder cancer? |
Badrinath Konety |
University of Minnesota |
PLCO |
Jan 18, 2018 |
PLCO-340 |
Statistical evaluation of diagnostic test under verification bias |
Khanh To Duc |
Department of Statistical Sciences, University of Padova, Padova, Italy |
PLCO |
Jan 18, 2018 |
PLCO-337 |
Risk analysis of prostate cancer occurrence based on PLCO data |
Lukasz Markiewicz |
Independent |
PLCO |
Jan 17, 2018 |
PLCO-332 |
Is the regular intake of tea (+/-added sugar) and broccoli (+/- other cruciferous vegetables) linked to the incidence of Prostate and breast Cancer? - An analysis of the PLCO cancer screening trial dataset |
Robert Thomas |
Bedford and Addenbrookes Cambridge University NHS Hospitals |
PLCO |
Jan 11, 2018 |
PLCO-335 |
A Comparison of Binary Classifiers Performance on Predicting Breast Cancer Diagnoses |
Vanessa Gutierrez |
Fordham University |
PLCO |
Jan 4, 2018 |
PLCO-336 |
Lung cancer prediction using artficial neural networks |
Saudagar Barde |
Smt kashibai navle college of engineering |
PLCO |
Jan 3, 2018 |
PLCO-334 |
Machine learning to predict risk from chest radiographs and clinical factors |
Michael Lu |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
PLCO |
Dec 19, 2017 |
PLCO-331 |
A simulation modeling study examining the downstream effects of follow-up schedules for screen-detected nodules |
Chung Yin (Joey) Kong |
Massachusetts General Hospital |
PLCO |
Nov 27, 2017 |
PLCO-317 |
A genome-wide association study of lifecourse weight change |
Sonja Berndt |
National Cancer Institute |
PLCO |
Nov 27, 2017 |
PLCO-325 |
Deep learning on Screening Data |
Elliot Smith |
Maxwell MRI |
PLCO |
Nov 27, 2017 |
PLCO-328 |
Towards personalized cancer treatment with deep learning |
Francesco Ciompi |
Radboud University Medical Center |
PLCO |
Nov 24, 2017 |
PLCOI-323 |
Simulation study as supplement to EEMS proposal 2017-0029, “Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort”. |
Barry Graubard |
National Cancer Institute |
PLCO |
Nov 10, 2017 |
PLCO-326 |
Common genetic variants and ovarian cancer screening in PLCO |
Nicolas Wentzensen |
National Cancer Institute, Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch |
PLCO |
Nov 8, 2017 |
PLCO-324 |
Multivitamin Use, Mortality, and Cancer: Leveraging Repeat Measures to Clarify the Impact of Multivitamin Use on Mortality and Cancer Risk |
Erikka Loftfield |
NCI |
PLCO |
Nov 8, 2017 |
PLCO-322 |
Metabolomics Profiles for Colorectal Cancer Risk Prediction within prospective Cohorts in th COMETS Consortium |
Jennifer Ose |
Huntsman Cancer Institute, University of Utah |
PLCO |
Oct 31, 2017 |
PLCO-320 |
Neural Network for Detection of Prostate Cancer. |
Przemysław Świderski |
Lodz University of Technology |
PLCO |
Oct 31, 2017 |
PLCO-319 |
Testing for association between month of birth and circulating levels of vitamin D among participants in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial |
Lahiru Handunnetthi |
University of Oxford |
PLCO |
Oct 23, 2017 |
PLCO-318 |
Biopsy Recommendation in Prostate Cancer Using Machine Learning Techniques |
TAHA KHAN |
FAST-NUCES Karachi |
PLCO |
Oct 16, 2017 |
PLCO-314 |
Prediction of a cancer in R language |
Lucia Plichtova |
University of Zilina - Slovakia |
PLCO |
Oct 12, 2017 |
PLCO-313 |